About UQDI

Turning scientific discoveries into better treatments.

The University of Queensland Diamantina Institute (UQDI) is a modern research facility where clinical and basic science converge in the translational research of cancer and disorders of immune regulation. Headed by Professor Matthew Brown, the Institute is host to over 200 researchers, students and support staff. It lays claim to global, world-changing discoveries such as the world’s first cervical cancer vaccine.

Based at Brisbane’s leading teaching hospital, the Princess Alexandra Hospital, The University of Queensland Diamantina Institute has strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields. Our researchers focus their efforts on turning their scientific discoveries into better treatments for diseases including a variety of cancers, osteoporosis, arthritis and other autoimmune diseases.

About UQDI section

History In 2007, the University of Queensland Diamantina Institute was established as the sixth research institute of The University of Queensland. The Institute was formed through the amalgamat...
Our Staff
Governance The University of Queensland Diamantina Institute Governance. As a research institute at The University of Queensland, the UQDI is recognised as a collaborative member of a non-profit academic institution. The...
Recruitment Working at UQDI. The UQDI houses approximately 200 researchers. Nearly half of these are postdoctoral researchers working in the various groups that...
Foreword from the Director
TRI Building The UQDI will be moving into the Translational Research Institute (TRI) in late 2012. TRI will be an Australian first and will see Australia play a leading role in intern...